RIG-I Activation Is Critical for Responsiveness to Checkpoint Blockade

被引:1
|
作者
Heidegger, Simon [1 ]
Wintges, Alexander [1 ]
Stritzke, Florian [1 ]
Steiger, Katja [2 ]
Koenig, Paul-Albert [3 ]
Engleitner, Thomas [4 ]
Fischer, Julius Clemens [5 ]
Makarov, Vladimir [6 ]
Winter, Christof [7 ]
Rad, Roland [4 ]
van den Brink, Marcel R. M. [8 ]
Ruland, Juergen [7 ]
Bassermann, Florian [1 ]
Chan, Timothy [9 ]
Haas, Tobias [1 ]
Poeck, Hendrik [1 ]
机构
[1] Tech Univ Munich, Dept Med 3, Klinikum Rechts Isar, Munich, Germany
[2] Tech Univ Munich, Inst Pathol, Klinikum Rechts Isar, Munich, Germany
[3] Univ Bonn, Bonn, Germany
[4] Tech Univ Munich, Inst Mol Oncol & Funct Genom, Klinikum Rechts Isar, Munich, Germany
[5] Tech Univ Munich, Dept Radiat Oncol, Klinikum Rechts Isar, Munich, Germany
[6] Mem Sloan Kettering Canc Ctr, Immunogen & Precis Oncol Platform, 1275 York Ave, New York, NY 10021 USA
[7] Tech Univ Munich, Inst Clin Chem & Pathobiochem, Klinikum Rechts Isar, Munich, Germany
[8] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[9] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA
关键词
D O I
10.1182/blood-2019-128724
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
624
引用
收藏
页数:3
相关论文
共 50 条
  • [1] RIG-I activation is critical for responsiveness to checkpoint blockade
    Heidegger, Simon
    Wintges, Alexander
    Stritzke, Florian
    Bek, Sarah
    Steiger, Katja
    Koenig, Paul-Albert
    Goettert, Sascha
    Engleitner, Thomas
    Oellinger, Rupert
    Nedelko, Tatiana
    Fischer, Julius C.
    Makarov, Vladimir
    Winter, Christof
    Rad, Roland
    van den Brink, Marcel R. M.
    Ruland, Juergen
    Bassermann, Florian
    Chan, Timothy A.
    Haas, Tobias
    Poeck, Hendrik
    SCIENCE IMMUNOLOGY, 2019, 4 (39)
  • [2] Selective engagement of the RIG-I pathway synergizes with checkpoint blockade in cancer immunotherapy
    Heideager, S.
    Kreppel, D.
    Bscheider, M.
    Wintges, A.
    Bek, S.
    Schmickl, M.
    Fischer, J. C.
    Lin, C-C
    Peschel, C.
    Haas, T.
    Poeck, H.
    Oncology Research and Treatment, 2015, 38 : 37 - 38
  • [3] The RIG-I Agonist 3pRNA Synergizes with Checkpoint Blockade in Cancer Immunotherapy
    Heidegger, Simon
    Kreppel, Diana
    Bscheider, Michael
    Wintges, Alexander
    Bek, Sarah
    Schmickl, Martina
    Ruland, Juergen
    Peschel, Christian
    van den Brink, Marcel
    Haas, Tobias
    Poeck, Hendrik
    BLOOD, 2015, 126 (23)
  • [4] RIG-I agonists boost the efficacy of anticancer vaccines and synergizes with immune checkpoint blockade
    Heidegger, S.
    Kreppel, M.
    Bek, S.
    Stritzke, F.
    Wintges, A.
    Fischer, J.
    Kalinke, U.
    Bassermann, F.
    Haas, T.
    Poeck, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 26 - 26
  • [5] RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockade
    Heidegger, Simon
    Kreppel, Diana
    Bscheider, Michael
    Stritzke, Florian
    Nedelko, Tatiana
    Wintges, Alexander
    Bek, Sarah
    Fischer, Julius C.
    Graalmann, Theresa
    Kalinke, Ulrich
    Bassermann, Florian
    Haas, Tobias
    Poeck, Hendrik
    EBIOMEDICINE, 2019, 41 : 146 - 155
  • [6] The molecular mechanism of RIG-I activation and signaling*
    Thoresen, Daniel
    Wang, Wenshuai
    Galls, Drew
    Guo, Rong
    Xu, Ling
    Pyle, Anna Marie
    IMMUNOLOGICAL REVIEWS, 2021, 304 (01) : 154 - 168
  • [7] Activation and regulation of pathogen sensor RIG-I
    Patel, Jenish R.
    Garcia-Sastre, Adolfo
    CYTOKINE & GROWTH FACTOR REVIEWS, 2014, 25 (05) : 513 - 523
  • [8] RIG-I activation inhibits ebolavirus replication
    Spiropoulou, Christina F.
    Ranjan, Priya
    Pearce, Melissa B.
    Sealy, Tara K.
    Albarino, Cesar G.
    Gangappa, Shivaprakash
    Fujita, Takashi
    Rollin, Pierre E.
    Nichol, Stuart T.
    Ksiazek, Thomas G.
    Sambhara, Suryaprakash
    VIROLOGY, 2009, 392 (01) : 11 - 15
  • [9] Structure and Dynamics of the Second CARD of Human RIG-I Provide Mechanistic Insights into Regulation of RIG-I Activation
    Ferrage, Fabien
    Dutta, Kaushik
    Nistal-Villan, Estanislao
    Patel, Jenish R.
    Sanchez-Aparicio, Maria T.
    De Ioannes, Pablo
    Buku, Angeliki
    Gonzalez Aseguinolaza, Gloria
    Garcia-Sastre, Adolfo
    Aggarwal, Aneel K.
    STRUCTURE, 2012, 20 (12) : 2048 - 2061
  • [10] Activation of the cytosolic RNA receptor RIG-I in tumor and immune cells triggers efficient anti-tumor immunity and synergizes with checkpoint blockade
    Heidegger, S.
    Alexander, W.
    Kreppel, D.
    Bscheider, M.
    Bek, S.
    Fischer, J.
    Schmickl, M.
    Ruland, J.
    Peschel, C.
    Haas, T.
    Poeck, H.
    EUROPEAN JOURNAL OF CANCER, 2016, 55 : S22 - S22